scholarly journals Giant cell tumour of the middle phalanx of the middle finger

2019 ◽  
Vol 12 (3) ◽  
pp. e229076 ◽  
Author(s):  
Nath Adulkasem ◽  
Dumnoensun Pruksakorn
Keyword(s):  
Giant Cell ◽  
Bone Grafting ◽  
Giant Cell Tumour ◽  
Middle Finger ◽  
Cell Tumour ◽  
Middle Phalanx ◽  
Recurrence Rates ◽  
Left Middle

Giant cell tumour (GCT) of bones in the hand is very rare, only 2% of all hand tumours, but unacceptably high recurrence rates (up to 90%) have been reported by several authors. Diagnosis can be challenging due to its rarity and enchondroma-mimicking characteristics. We report on a case of GCT of the middle phalanx of the left middle finger in a 49-year-old woman who underwent middle phalanx resection and reconstruction with bone grafting. At the 1-year follow-up, no evidence of recurrence was detected and the patient was pain-free.

Trans-Foveal Approach for Curettage and Bone Grafting of a Giant Cell Tumour in the Femoral Head

2016 ◽  
Vol 26 (6) ◽  
pp. 612-614
Author(s):  
Hannes A. Rüdiger ◽  
Krzystof Piasecki ◽  
Fabio Becce ◽  
Stéphane Cherix
Keyword(s):  
Femoral Head ◽  
Giant Cell ◽  
Bone Grafting ◽  
Giant Cell Tumour ◽  
Cell Tumour ◽  
Case Presentation ◽  
Surgical Access ◽  
Surgical Dislocation ◽  
Articular Cartilage Lesions

Background Surgical access to benign neoplastic lesions of the femoral head are associated with significant morbidity, including contamination of intra-osseous access tracks, articular cartilage lesions, avascular bone necrosis or tumour recurrence due to incomplete curettage. Case presentation We present a case of a 20-year-old female with a giant cell tumour in the femoral head, which was treated with curettage through a trans-foveal approach and bone grafting. This technique includes a surgical dislocation of the hip with trochanteric osteotomy. Results At the latest follow-up at 2 years, there was no evidence of local recurrence or avascular necrosis on MRI, and the patient was pain free and back to sports.

GIANT CELL TUMOUR OF TENDON SHEATH OF TENDOACHILLES-A CASE REPORT

2021 ◽  
pp. 10-11
Author(s):  
K Srinivasa Reddy ◽  
K Anusha ◽  
K B Vijaya Mohan Reddy
Keyword(s):  
Case Report ◽  
Giant Cell ◽  
Giant Cell Tumour ◽  
Tendon Sheath ◽  
Cell Tumour ◽  
High Rate ◽  
Uncommon Tumour

Giant cell tumour arises from the synovium of tendon sheath, joints, or bursae,mostly affects adults between 30 and 50 years of age, and is slightly more common in females.Giant cell tumour of tendon sheath of tendoachilles is uncommon tumour. Usually it has a high rate of recurrence. In this article we report the case of a 32 year old female with Giant cell tumour of tendoachilles treated by excision with no reccurence after 7 months of follow up

scholarly journals RECURRENT GIANT CELL TUMOUR OF THE FLEXOR TENDON SHEATH OF THE DISTAL PALM – A CASE REPORT

2020 ◽  
pp. 1-2
Author(s):  
Surya Rao Rao Venkata Mahipathy ◽  
Alagar Raja Durairaj ◽  
Narayanamurthy Sundaramurthy ◽  
Anand Prasath Jayachandiran ◽  
Volga Harikrishnan
Keyword(s):  
Giant Cell ◽  
Giant Cell Tumour ◽  
Flexor Tendon ◽  
Imaging Modality ◽  
Benign Lesion ◽  
Tendon Sheath ◽  
Cell Tumour ◽  
Recurrence Rates ◽  
Flexor Tendon Sheath ◽  
Tenosynovial Giant Cell Tumour

Giant cell tumor of the tendon sheath is a common benign lesion of the hand. They are also known as tenosynovial giant cell tumours. Magnetic resonance imaging is the imaging modality of choice and the current treatment is surgical excision of the lesion. This lesion is particularly known for its high recurrence rates. Here, we present a case of a recurrent tenosynovial giant cell tumour of the flexor tendon sheath of the index finger at the distal palmar crease. Diagnosis was confirmed by MRI and the lesion was excised. Histopathology revealed a localized type of tenosynovial giant cell tumour.

scholarly journals Recurrent giant cell tumour of the maxillary sinus and pterygoid process treated with denosumab

2018 ◽  
pp. bcr-2018-225095
Author(s):  
Duarte Rosa ◽  
Raquel Baptista Dias ◽  
João Cunha Salvador ◽  
Alexandra Borges
Keyword(s):  
Maxillary Sinus ◽  
Giant Cell ◽  
Giant Cell Tumour ◽  
Neck Surgery ◽  
Cell Tumour ◽  
Pterygoid Process ◽  
Bone Expansion ◽  
The Right ◽  
Denosumab Treatment

We report the case of a 74-year-old man with a giant cell tumour (GCT) of the right maxilla and pterygoid process. The patient presented to the maxillofacial and head and neck surgery clinic with an ulcerated lesion of the hard palate. Initial workup with CT revealed a mass within the right maxillary sinus and pterygoid process with associated bone expansion and erosion. Biopsy showed a GCT with mucosal ulceration. Two years after surgical resection, a follow-up CT revealed tumour recurrence involving the right pterygoid process and lateral pterygoid muscle. The patient was then proposed for therapy with denosumab. Under denosumab treatment, the lesion maintained stable dimensions and became sclerotic and heavily ossified.

scholarly journals Curettage and Radiotherapy of Giant Cell Tumour of the Sacrum: A Case Report with a 10-Year Follow-up

2005 ◽  
Vol 13 (2) ◽  
pp. 171-173 ◽  
Author(s):  
M Kanamori ◽  
K Ohmori
Keyword(s):  
Case Report ◽  
Giant Cell ◽  
Adjuvant Radiotherapy ◽  
Posterior Approach ◽  
Giant Cell Tumour ◽  
Cell Tumour ◽  
Successful Reduction

A case report of a 53-year-old woman with giant cell tumour of the sacrum is presented. Initial curettage was performed through a posterior approach and the patient was relieved of pain and discharged. However, 6 months later the patient was readmitted with a tumour that had progressed towards the L5 vertebra. A further curettage followed by adjuvant radiotherapy resulted in successful reduction of the tumour. Ten years after the operation, there was no recurrence or metastasis.

Central Column Reconstruction Following Total Resection of a Third Metacarpal Giant Cell Tumour

2005 ◽  
Vol 30 (6) ◽  
pp. 650-655 ◽  
Author(s):  
J. Y. L. LEE ◽  
R. W. H. PHO ◽  
D. S. C. YEO
Keyword(s):  
Giant Cell ◽  
Structural Integrity ◽  
Giant Cell Tumour ◽  
Middle Finger ◽  
Metacarpophalangeal Joint ◽  
Cell Tumour ◽  
Wide Resection ◽  
Tumour Control ◽  
Aesthetic Result ◽  
Central Column

A wide resection of a giant cell tumour involving the entire middle metacarpal is presented. Reconstruction preserving the central column and metacarpophalangeal joint was achieved using autologous iliac crest bone as a spacer and structural support. The fibro-osseous cartilage portion of the iliac graft was used as a “hemi-joint” replacement. By using a bridging bone graft and screw to fuse the adjacent proximal phalanges of the middle and index fingers, a stable “internal syndactyly” was achieved. Although independent index and middle finger motion was sacrificed, the approach allowed wide resection for local tumour control, re-established structural integrity, preserved metacarpophalangeal joint motion and allowed early motion. The aesthetic result was also good.

scholarly journals PROSPECTIVE INTERVENTIONAL STUDY OF ASSESS FUNCTIONAL OUTCOME OF GIANT CELL TUMOUR OF DISTAL END RADIUS TREATED BY EN BLOE RESECTION AND RECONSTRUCTION BY ULNAR TRANSLOCATION

2021 ◽  
Vol 5 (8) ◽  
Author(s):  
Suresh Bishnoi ◽  
Sanjay Yadav ◽  
Pankaj Jain ◽  
Shreekant Meena
Keyword(s):  
Giant Cell ◽  
Soft Tissues ◽  
Giant Cell Tumour ◽  
Wrist Joint ◽  
Cell Tumour ◽  
Recurrence Rates ◽  
Superficial Infection ◽  
Musculoskeletal Tumor ◽  
Musculoskeletal Tumor Society ◽  
Msts Score

Background: Giant cell tumour (GCT) of bone is a relatively rare, locally aggressive benign neoplasm associated with a wide pathological spectrum, ranging from latent benign to highly recurrent and, occasionally, malignant metastatic potential. Methods: This retrospective study was conducted on 30 hospitalized patients for surgery in in Jaipur.  We followed up all patients with GCT of the distal radius who were treated with en bloc excision and custom prosthetic replacement. All cases were evaluated based on clinical and radiological examinations, passive range of motion (ROM) of the wrist joint, complications, and Musculoskeletal Tumor Society (MSTS) score. Results: Mean follow-up period was 52.36 months, mean resected length of the radius was 7.11±2.31 cm. One patient had tumor recurrence in the soft tissues after 16.32±2.31 months (recurrence rate 10.00 %). No patient had fracture, recurrence in the bone, metastases, or immune rejection. No complications were seen, such as loosening, rupture, or dislocation of the custom prosthesis. One patient developed superficial infection at the operative site which resolved after a course of antibiotics for 4 weeks. One patient experienced pain, which could be endured without the need for analgesics. Average ROM was 40.6° of dorsiflexion, 29.8° of volar flexion, 46.2° of supination, and 37.8° of pronation. Mean grip strength was 70 % (41–84 %). Overall revised MSTS score averaged 81.36 % with one being excellent, five good, and five satisfactory. Conclusion: The optimal treatment for GCTs arising around the knee remains controversial. Despite the trend towards better oncological control of this tumour after wide resections, the recurrence rates achieved through a more conservative procedure such as the curettage-based interventions seem to be acceptable. Additionally, curettage and local adjuvants allow for overall better function of the knee, in particular with proximal tibia GCTs. Keywords: GCT, MSTS, ROM

Giant Cell Tumour of Metacarpal with Pulmonary and Skeletal Metastases

1996 ◽  
Vol 21 (1) ◽  
pp. 126-132 ◽  
Author(s):  
B. K. S. SANJAY ◽  
D. A. YOUNGE
Keyword(s):  
Giant Cell ◽  
Giant Cell Tumour ◽  
Pulmonary Metastases ◽  
Cell Tumour ◽  
Skeletal Metastases ◽  
Long Term Prognosis

A case of giant cell tumour of the left fifth metacarpal with pulmonary and skeletal metastases is reported with follow-up of 14 years. The pulmonary metastases were treated by chemotherapy, but the size of the metastatic nodules continued to increase, and no further treatment was given. The pulmonary metastatic nodules started to regress 8 years after the diagnosis without any treatment, and had disappeared after 14 years. The skeletal metastases were unchanged at the latest follow-up. Both pulmonary and skeletal metastases have been asymptomatic for the 14 years after they were diagnosed. It is suggested that pulmonary metastases of benign giant cell tumour has a good long-term prognosis and these patients should be kept under observation only, avoiding extensive lobectomy, chemotherapy or radiotherapy.

Sign in / Sign up

Export Citation Format

Share Document